MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

26 Jul 2024 Evaluate
The sales for the June 2024 quarter moved down to Rs. 388.27 millions as compared to Rs. 495.88 millions during the year-ago period.Net profit declined -25.30% to Rs. 132.37 millions from Rs. 177.21 millions.A decline of 190.75 millions was observed in the OP in the quarter ended June 2024 from 245.81 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 388.27 495.88 -21.70 388.27 495.88 -21.70 1698.22 1483.85 14.45
Other Income 5.24 10.75 -51.26 5.24 10.75 -51.26 43.66 65.88 -33.73
PBIDT 190.75 245.81 -22.40 190.75 245.81 -22.40 831.00 802.17 3.59
Interest 0.66 0.25 164.00 0.66 0.25 164.00 2.29 1.76 30.11
PBDT 190.09 245.56 -22.59 190.09 245.56 -22.59 828.71 800.41 3.54
Depreciation 11.48 7.49 53.27 11.48 7.49 53.27 35.36 25.76 37.27
PBT 178.61 238.07 -24.98 178.61 238.07 -24.98 793.35 774.65 2.41
TAX 46.24 60.86 -24.02 46.24 60.86 -24.02 201.71 194.96 3.46
Deferred Tax 0.53 0.96 -44.79 0.53 0.96 -44.79 3.75 2.55 47.06
PAT 132.37 177.21 -25.30 132.37 177.21 -25.30 591.64 579.69 2.06
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 49.13 49.57 -0.89 49.13 49.57 -0.89 48.93 54.06 -9.48
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..